Worldwide: Securities

Subscribe
Business law and corporate law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics that involve business and corporate law produced by specialists working in this area every day.
Article
Developments In Securities Fraud Class Actions Against U.S. Life Sciences Companies
Last year marked a decrease in federal securities class action filings, with plaintiffs filing 207 cases in 2025, down from 225 in 2024. However, life sciences companies remained popular targets, accounting for 47 of these filings.1 In this White Paper, we examine 2025's filing and decision trends and provide insights to help life sciences companies navigate the litigation landscape prudently.
United States Commercial
D
Dechert
See more